FindTrial
Sign In

Long term effects of definitive chemoradiotherapy on respiratory function tests in patients with locally advanced (non) small cell lung carcinoma

Long term effects of definitive chemoradiotherapy on respiratory function tests in patients with locally advanced (non) small cell lung carcinoma - Long term effects of chemoradiotherapy on respiratory function in (N)SCLC

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42847
Enrollment
45
Registered
2016-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(N)SCLC lungcancer

Interventions

None listed

Sponsors

Haga ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. * 18 years of age 2. Histologically of cytologically confirmed diagnosis of (N)SCLC 3. Stage II/III non operable disease 4. Treatment with definite concurrent of sequential chemoradiation between November 2010 and November 2015 5. Lung function testing including DLCO measurement pre-treatment is available 6. Signed written informed consent

Exclusion criteria

Exclusion criteria: Not being able to have another lung function test done (due to death or poor condition)

Design outcomes

Primary

MeasureTime frame
The change of lung function at least one year after chemoradiotherapy (long term changes) in our clinic.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)